Oral contraceptives and myocardial infarction: results of the MICA case-control study - Wikidata - awgldk - TriplyDB

Oral contraceptives and myocardial infarction: results of the MICA case-control study

Oral contraceptives and myocardial infarction: results of the MICA case-control study

http://www.wikidata.org/entity/Q33619425

about

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke Oral contraceptives and myocardial infarction.Study confirms tendency towards lower risk of myocardial infarction with second generation oral contraceptives in UK.The place of combined oral contraceptives in contraception.Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Estrogens, progestogens and thrombosis.Regional variation in incidence and case fatality of myocardial infarction among young women in England, Scotland and Wales.Combined oral contraceptives and the risk of myocardial infarction.Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.Effect of Oral Contraceptive Pills on the Blood Serum Enzymes and DNA Damage in Lymphocytes Among Users Contraceptive hormone use and cardiovascular disease Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.Hormonal contraception, thrombosis and age.Dyslipidemia and cardiovascular disease in women.The third generation oral contraceptive controversy. The evidence shows they are less safe than second generation pills.The third generation pill controversy ("continued").Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response.Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women.Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome.Low-dose oral contraceptive-induced acute myocardial infarction.Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.2013 ESH/ESC Guidelines for the management of arterial hypertension Measuring Perceptions of Synergistic Circulatory Disease Risk Due to Smoking and the Oral Contraceptive Pill Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis Costs of seeking ethics approval before and after the introduction of multicentre research ethics committees

P2860

Q24187746-6B155661-3BD9-4486-B5EF-6779957DCC51 Q33576311-D3BED31F-4964-43D8-AC11-03F91E278EE0 Q33798517-E20BD203-8A39-4766-9205-BD30D16CBE90 Q34039806-86CD735C-41DB-4E88-8D20-C4BC345CEF93 Q34086042-CF7A0434-BED8-4C3B-AC89-D6873D6A1E18 Q35181580-DC2AFAFC-D607-4231-A29F-2820022E657B Q35401543-F5490884-2C66-4939-88B2-CA1819116776 Q35565498-D39A1312-91C1-447A-B6CE-E58B7EB2872F Q36887503-5B4986C7-C400-43A9-88E6-51515830BAB7 Q37012991-5C8242A8-F706-43F8-B88F-C1B3FF3023D3 Q37138852-B41184BA-9B9B-4A70-A484-2B59CD47C7C0 Q37763371-DE691709-BB9B-4BF0-9C87-F7328E9B5EFD Q37809855-95C8F46D-136B-4F98-9ADB-E35669C401A6 Q38110189-A3A7A6AA-0113-443F-9BF4-9BB0EDB73966 Q38250178-FEC4B679-1869-4AF5-8630-85ED20B57F58 Q38508952-5CBFD7D6-0CCC-46BD-9D08-31F03CC3D366 Q42764260-2A2B4632-0C17-4FBD-933A-8587FA3DBCD1 Q42773003-2849C68A-092C-42D8-8C96-B9821B02CC56 Q46892234-1071F3C8-AF5A-453B-8028-88BD322602C7 Q46921099-C65895DF-13E0-418D-9919-987FF7E38685 Q47137256-6233E810-0956-4F1A-A2E5-47619BAE8DE1 Q48006214-07365A32-9B95-4A60-B85C-EF5DD065D628 Q51039118-B275062E-50FC-48B2-8E05-515DE86F30FB Q56970511-1234D77D-1D8B-4573-9C19-C2F60796EE6C Q57266495-8F40677D-A388-4518-867D-BFE69B3CC04D Q57418618-81A5BC3F-6388-4017-90F3-AA0E6DDE1041 Q58670741-D29A9EF2-A22C-4548-B26F-50EBC4EE6976

P2860

Oral contraceptives and myocardial infarction: results of the MICA case-control study

http://www.wikidata.org/entity/Q33619425

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@ast

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@en

type

label

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@ast

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@en

prefLabel

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@ast

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@en

P1433

Q33619425-9B4F13E4-2098-4CE3-A8EE-E9C7E54FBADF

P1476

Q33619425-5B55EAE5-8A47-488A-A2B7-76A7A1811233

P2093

Q33619425-0992B865-D273-49C6-B9E2-085F923A489A

Q33619425-13123A25-D91A-4A7C-9C19-9A53323F6C90

Q33619425-3BA5FBCE-99D4-4D27-BCDF-3618CBB57E10

Q33619425-475A95D6-1B05-45C3-AED2-6A5FE7998463

Q33619425-50687F50-728C-4170-85EA-386D5E32E192

Q33619425-E2F582E2-5E5A-482C-B96A-C06DE417AF0A

Q33619425-F8C8B836-F3F3-464D-9BC7-CC0D02E5B87E

P2860

Q33619425-111F2D6C-9845-4E5C-B184-6AEF79E449B9

Q33619425-2FB1C3BF-39B1-4B40-8D49-58689F81D45B

Q33619425-4A1E3DC5-98E9-493A-9363-27C4048E161E

Q33619425-853D16B3-CDB5-437E-97C6-1E691B94AC99

Q33619425-A0398B62-BD1A-48D6-B3E5-B1E0222A44F5

Q33619425-C238381F-C89C-4411-96A2-4B3B36D7DDAC

P304

Q33619425-25E5AC0F-193C-40D4-820E-1E43100C19FB

P31

Q33619425-F940E65A-E95E-4B39-8512-669A47C07BC8

P356

Q33619425-AA93F14D-A33B-4938-B27E-8568B693B0A0

P407

Q33619425-A3A81696-D51E-4AF5-8602-3720349F0DFE

P433

Q33619425-119B13DB-D470-4F45-A627-378EFD7D413F

P478

Q33619425-1067381E-A5ED-43D9-BE18-B1955FACC381

P50

Q33619425-D58083BD-60F8-43F9-B0C2-869ED50A2E47

P577

Q33619425-97101511-0733-48C2-93B9-70134A878A80

P5875

Q33619425-5703D02C-96DA-451D-BB1E-2E1B97E929F1

P698

Q33619425-F9BD7F7A-FC58-4A6F-BE53-50083BCC7002

P932

Q33619425-097125B1-FC1A-4B0A-BE8D-4DAE21A0D972

P356

BMJ.318.7198.1579

P1433

P1476

Oral contraceptives and myocardial infarction: results of the MICA case-control study

@en

P2093

B Faragher

http://www.w3.org/2001/XMLSchema#string

C McCollum

http://www.w3.org/2001/XMLSchema#string

L de Caestecker

http://www.w3.org/2001/XMLSchema#string

M Thorogood

http://www.w3.org/2001/XMLSchema#string

N Dunn

http://www.w3.org/2001/XMLSchema#string

R Mann

http://www.w3.org/2001/XMLSchema#string

S Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

A study to determine the sensitivity and specificity of hospital discharge diagnosis data used in the MICA study.

Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study.

The primary prevention of coronary heart disease in women.

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.

Myocardial infarction in users of low-dose oral contraceptives.

Risk factors for myocardial infarction in young women

P304

1579-1583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.318.7198.1579

http://www.w3.org/2001/XMLSchema#string

P407

P433

7198

http://www.w3.org/2001/XMLSchema#string

P478

318

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Macdonald

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232267289

http://www.w3.org/2001/XMLSchema#string

P698

10364115

http://www.w3.org/2001/XMLSchema#string

P932

28136

http://www.w3.org/2001/XMLSchema#string